beta-Adrenergic Agonist
35 drugs across 18 manufacturers|24 Generic,11 Brand
The beta-Adrenergic Agonist class contains 35 NDCs from 18 manufacturers (24 generic, 11 brand), at an average NADAC of $94.67 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
35
24G / 11B
Manufacturers
18
Avg $94.6709/unit
Avg 7d Change
+0.18%
Across 11 drugs with changes
7d Activity
of 35 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
18 manufacturers producing drugs in this therapeutic class(2 pricing outliers)
and 6 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Viatris Specialty LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
epinephrine market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the beta-Adrenergic Agonist class?
The beta-Adrenergic Agonist class contains 35 NDCs from 18 manufacturers — 24 generic and 11 brand products.
What is the average price of beta-Adrenergic Agonist drugs?
The average NADAC for the beta-Adrenergic Agonist class is $94.6709 per unit across 35 NDCs.
Is generic cheaper than brand in the beta-Adrenergic Agonist class?
Among products priced per ML, the average generic NADAC in this class is $4.3833, versus $2.1513 for brand — brand is currently about 51% cheaper on average.
Which manufacturers make beta-Adrenergic Agonist drugs?
18 manufacturers make drugs in the beta-Adrenergic Agonist class. Ranked by number of NDCs, the largest are Viatris Specialty LLC (4), Amneal Pharmaceuticals of New York LLC (4), Fresenius Kabi USA, LLC (4), kaleo, Inc (3), Par Health USA, LLC (3).
How has beta-Adrenergic Agonist pricing changed recently?
Over the past 7 days, 5 NDCs in this class rose and 6 fell, with a class-wide average change of +0.2%.